These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37248764)

  • 81. RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.
    Rao B; Li J; Ren T; Yang J; Zhang G; Liu L; Wang H; Huang M; Ren Z; Yu Z
    Front Cell Dev Biol; 2021; 9():686547. PubMed ID: 34350180
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
    J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
    [TBL] [Abstract][Full Text] [Related]  

  • 83. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma.
    Che Y; Wang G; Xia Q
    Front Genet; 2022; 13():937310. PubMed ID: 36105112
    [No Abstract]   [Full Text] [Related]  

  • 84. Increased expression of TBC1D10B as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma.
    Fan L; Tang Y; Li J; Huang W
    Sci Rep; 2023 Jan; 13(1):335. PubMed ID: 36611046
    [TBL] [Abstract][Full Text] [Related]  

  • 85. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
    Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
    Front Immunol; 2021; 12():612139. PubMed ID: 33679751
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prefoldin and prefoldin-like complex subunits as predictive biomarkers for hepatocellular carcinoma immunotherapy.
    Zhao H; Chen C; Yang C; Mo S; Zhao H; Tian Y
    Pathol Res Pract; 2022 Apr; 232():153808. PubMed ID: 35217267
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
    Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
    Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
    [No Abstract]   [Full Text] [Related]  

  • 88. The effect of
    Liang J; Huang Y; Yang C; Huang S; Xie J; Nong X; Liu J; Zhang Y; Zhang Z
    J Gastrointest Oncol; 2021 Dec; 12(6):3008-3021. PubMed ID: 35070426
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    Li R; Cui X; Sun W; Yang Z; Shen X; Zhu C
    Comb Chem High Throughput Screen; 2023; 26(7):1311-1323. PubMed ID: 35993469
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 91. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
    Tang M; Liao M; Ai X; He G
    Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 95. Roles of diencephalon/mesencephalon homeobox 1 in the development and prognosis of hepatocellular carcinoma.
    Huang X; Xiang L; Liu W; Li M; Ren A; Chen Z; Zheng C; Chengcong C; Liu J; Yuan Y
    Ann Hepatol; 2021; 24():100314. PubMed ID: 33524552
    [TBL] [Abstract][Full Text] [Related]  

  • 96. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
    Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
    Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression.
    Cai C; Peng X; Zhang Y
    Bioengineered; 2021 Dec; 12(1):7007-7019. PubMed ID: 34551671
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
    Sun Q; Liu P; Long B; Zhu Y; Liu T
    Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Transcriptome Analysis Revealed a Highly Connected Gene Module Associated With Cirrhosis to Hepatocellular Carcinoma Development.
    Shan S; Chen W; Jia JD
    Front Genet; 2019; 10():305. PubMed ID: 31001331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.